We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

By LabMedica International staff writers
Posted on 15 Nov 2024

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. More...

However, traditional tests are often underutilized due to the need for expensive equipment, specialized consumables, and trained professionals to collect blood, process the sample, and interpret the results. This limitation has led to an increased prevalence and severity of conditions related to blood hemoglobin, such as anemia, which affects more than 25% of the global population despite being easily treatable and preventable. A new mobile health solution now offers a way to make blood hemoglobin testing more accessible and affordable by leveraging a device most people already own: a smartphone. With this technology, users can quickly and noninvasively measure their blood hemoglobin levels by simply taking a picture or screenshot of the lower inner eyelid, providing immediate and reliable testing at the point of care and beyond.

HemaChrome LLC (West Lafayette, IN, USAhas developed a smartphone-based solution that utilizes algorithms to instantly and noninvasively assess blood hemoglobin levels. Developed in collaboration with Purdue University (West Lafayette, IN, USA), this machine learning-powered technology transforms a smartphone or computer camera into a hyperspectral imager by using spectroscopy and computational algorithms. The system enables users to quantify and evaluate blood hemoglobin content from a digital image of the inner eyelid, making it possible for clinicians to perform point-of-care, home-based, and remote diagnostics at a fraction of the cost of traditional methods.

To ensure high accuracy, HemaChrome’s technology incorporates a groundbreaking patent-pending process that extracts true colors from a digital image with an unprecedented level of precision. While the noninvasive, affordable technology can benefit all users, it will be particularly impactful for underserved populations where anemia is widespread. Anemia often indicates the presence of several health conditions, making early diagnosis crucial. However, many individuals, especially in low-resource areas, lack access to proper testing and remain unaware of their condition. HemaChrome's technology offers a cost-effective and accessible solution to address this diagnostic gap, helping ensure timely treatment for vulnerable groups. HemaChrome is continuing to refine its algorithms and plans to release a minimally viable product by late 2025.

Related Links:
HemaChrome LLC
Purdue University


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Serological Pipet Controller
PIPETBOY GENIUS
New
Silver Member
Quality Control Material
Multichem ID-B
New
PlGF Test
Quidel Triage PlGF Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The RNA-seq based diagnostic test for pediatric leukemia ensures better outcomes for children with this common cancer (Photo courtesy of Qlucore)

RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia

A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.